Kane Biotech Inc. announced a non-brokered private placement of up to 10,000,000 shares at a price of CAD 0.10 per share for gross proceeds of CAD 1,000,000 on March 15, 2022. The transaction is subject to receipt of all necessary approvals, including approval of the TSX Venture Exchange.